| Dr Diana Nguyen, PHARMD | |
|
1425 S Main St, Walnut Creek, CA 94596-5318 | |
| (925) 295-6301 | |
| (925) 295-6290 |
| Full Name | Dr Diana Nguyen |
|---|---|
| Gender | Female |
| Speciality | Pharmacist |
| Location | 1425 S Main St, Walnut Creek, California |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1790931897 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 183500000X | Pharmacist | 59184 (California) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Dr Diana Nguyen, PHARMD 1425 S Main St, Walnut Creek, CA 94596-5318 Ph: (925) 295-6301 | Dr Diana Nguyen, PHARMD 1425 S Main St, Walnut Creek, CA 94596-5318 Ph: (925) 295-6301 |
News Archive
The Patient Protection and Affordable Care Act aims for a delicate balance that even its champions acknowledge as highly challenging: Making medical services affordable for tens of millions of uninsured Americans, and yet restraining the expenditures needed to vastly expand coverage. To grasp why the reform bill risks missing both goals - and why the measure's margin for error is so perilously narrow - it's crucial to follow the debate over its central provision, what it calls the "Essential Health Benefits" package.
Transition Therapeutics Inc. announced today that a clinical study of gastrin analogue TT-223 in combination with a Lilly proprietary GLP-1 analogue in patients with type 2 diabetes did not meet its efficacy endpoints. Given these findings, there will be no further development of TT-223.
Theraclone Sciences, Inc., announced that Zenyaku Kogyo Co. Ltd., has exercised its option for an exclusive license in the Japan territory to Theraclone's influenza monoclonal antibody program. The collaboration utilizes Theraclone's I-STAR™ technology to discover broadly protective monoclonal antibodies for the treatment of pandemic influenza and severe seasonal influenza.
Cancer of the lower esophagus develops almost exclusively in patients with Barrett's esophagus, an otherwise benign complication of esophageal reflux that affects approximately 3 million Americans. Although the prognosis of patients diagnosed with esophageal cancer is poor, the chances of successful treatment increase significantly if the disease is detected at an early dysplastic stage.
› Verified 1 days ago
Ly Ly Choy, Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 2880 Shadelands Dr Ste 201, Walnut Creek, CA 94598 Phone: 925-979-6832 | |
Susan Ferrante, Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 2880 Shadelands Dr Ste 201, Walnut Creek, CA 94598 Phone: 925-979-6802 | |
Connie Liu, Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 1425 S Main St, Walnut Creek, CA 94596 Phone: 925-295-6415 | |
Elizabeth Linda Farr, BPHARM Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 1425 S Main St, Walnut Creek, CA 94596 Phone: 925-295-4655 | |
Dr. Vincent Gee Lum Ko, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 1526 Palos Verdes Mall, Walnut Creek, CA 94597 Phone: 808-389-0086 | |
Dr. Jesse Toor, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 1844 San Miguel Dr Ste 105, Walnut Creek, CA 94596 Phone: 925-937-6800 Fax: 925-937-4149 | |
Judy Kwak, Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 320 Lennon Ln, Walnut Creek, CA 94598 Phone: 925-906-2503 |